HCPCS Level II drug code
J2260 — Injection, milrinone lactate, 5 mg
In short
J2260 is the HCPCS Level II code for injection, milrinone lactate, 5 mg. CMS assigns NDCs for Milrinone In Dextrose, Milrinone Lactate and Milrinone Lactate In Dextrose to it. One billing unit is 5 mg. The Medicare Part B payment limit is $1.143 per unit (October 1, 2026 through December 31, 2026).
Code
CMS HCPCS file- Descriptor
- Injection, milrinone lactate, 5 mg
- Short descriptor
- Inj milrinone lactate / 5 mg
- Code set
- HCPCS Level II, maintained by CMS
- Effective
- Jan 1, 2018
The billing unit is read from the descriptor. Confirm it against the CMS file before billing.
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Units and claim line
Units = dose given ÷ 5 mg. For example, 500 mg is 100 units. Enter the dose to get the units and the NDC line for the CMS-1500 and the 837P.
Enter the dose given to build the claim line.
NDCs billed under J2260
CMS’s ASP NDC–HCPCS crosswalk (effective October 1, 2026 through December 31, 2026) assigns 35 NDCs to J2260 for Milrinone In Dextrose, Milrinone Lactate and Milrinone Lactate In Dextrose. Billing units per package are CMS’s figures for this code’s unit.
| Drug | NDC (11-digit) | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| Milrinone In Dextrose | 00143-9718-10 | Hikma Pharmaceuticals USA Inc. | 10 × 200 | 80 |
| Milrinone In Dextrose | 00143-9719-10 | Hikma Pharmaceuticals USA Inc. | 10 × 100 | 40 |
| Milrinone In Dextrose | 00338-6010-48 | Baxter Healthcare Corporation | 100 | 4 |
| Milrinone In Dextrose | 00338-6011-37 | Baxter Healthcare Corporation | 200 | 8 |
| Milrinone In Dextrose | 00409-2045-10 | Pfizer Inc | 10 × 100 | 40 |
| Milrinone In Dextrose | 25021-0313-82 | Sagent Pharmaceuticals | 10 × 100 | 40 |
| Milrinone In Dextrose | 25021-0313-87 | Sagent Pharmaceuticals | 10 × 200 | 80 |
| Milrinone In Dextrose | 55150-0287-10 | Eugia US LLC | 10 × 100 | 40 |
| Milrinone In Dextrose | 55150-0288-10 | Eugia US LLC | 10 × 200 | 80 |
| Milrinone Lactate | 00143-9326-10 | Hikma Pharmaceuticals USA Inc. | 10 × 20 | 40 |
| Milrinone Lactate | 00143-9373-10 | Hikma Pharmaceuticals USA Inc. | 10 × 10 | 20 |
| Milrinone Lactate | 00143-9374-10 | Hikma Pharmaceuticals USA Inc. | 10 × 20 | 40 |
| Milrinone Lactate | 00143-9708-01 | Hikma Pharmaceuticals USA Inc. | 50 | 10 |
| Milrinone Lactate | 00143-9709-10 | Hikma Pharmaceuticals USA Inc. | 10 × 20 | 40 |
| Milrinone Lactate | 00143-9710-10 | Hikma Pharmaceuticals USA Inc. | 10 × 10 | 20 |
| Milrinone Lactate | 00409-0212-01 | Pfizer Inc | 10 × 10 | 20 |
| Milrinone Lactate | 00409-0212-02 | Pfizer Inc | 10 × 20 | 40 |
| Milrinone Lactate | 00409-0212-03 | Pfizer Inc | 50 | 10 |
| Milrinone Lactate | 63323-0617-10 | FreseniUS Kabi USA, LLC | 10 × 10 | 20 |
| Milrinone Lactate | 63323-0617-20 | FreseniUS Kabi USA, LLC | 10 × 20 | 40 |
| Milrinone Lactate | 63323-0617-50 | FreseniUS Kabi USA, LLC | 50 | 10 |
| Milrinone Lactate | 65145-0121-10 | Caplin Steriles USA Inc. | 10 × 20 | 40 |
| Milrinone Lactate | 65145-0122-01 | Caplin Steriles USA Inc. | 50 | 10 |
| Milrinone Lactate | 65145-0176-10 | Caplin Steriles USA Inc. | 10 × 100 | 40 |
| Milrinone Lactate | 70069-0807-10 | Somerset Pharma, LLC | 10 × 10 | 20 |
| Milrinone Lactate | 70069-0808-10 | Somerset Pharma, LLC | 10 × 20 | 40 |
| Milrinone Lactate | 70069-0809-01 | Somerset Pharma, LLC | 50 | 10 |
| Milrinone Lactate | 71288-0200-11 | Meitheal Pharmaceuticals Inc. | 10 × 10 | 20 |
| Milrinone Lactate | 71288-0200-21 | Meitheal Pharmaceuticals Inc. | 10 × 20 | 40 |
| Milrinone Lactate | 71288-0200-50 | Meitheal Pharmaceuticals Inc. | 50 | 10 |
| Milrinone Lactate | 72485-0501-10 | Armas Pharmaceuticals Inc. | 10 × 10 | 20 |
| Milrinone Lactate | 72485-0502-10 | Armas Pharmaceuticals Inc. | 10 × 20 | 40 |
| Milrinone Lactate | 72485-0503-01 | Armas Pharmaceuticals Inc. | 50 | 10 |
| Milrinone Lactate In Dextrose | 70069-0872-10 | Somerset Pharma, LLC | 10 × 100 | 40 |
| Milrinone Lactate In Dextrose | 70069-0873-10 | Somerset Pharma, LLC | 10 × 200 | 80 |
J2260: common questions
- Is J2260 a CPT code?
- No. J2260 is a HCPCS Level II code, maintained by CMS, that identifies the drug supplied. CPT codes are five-digit numbers from the AMA that describe services. Giving the drug, for example an injection or infusion, is usually reported with a separate CPT administration code. CPT codes for drug administration.
- What NDCs are billed under J2260?
- CMS's ASP crosswalk for October 1, 2026 through December 31, 2026 lists 35 NDCs under J2260, for Milrinone In Dextrose, Milrinone Lactate and Milrinone Lactate In Dextrose. The table on this page shows each one with its billing units per package.
- What is the Medicare payment limit for J2260?
- $1.143 per 5 mg, effective October 1, 2026 through December 31, 2026, from CMS's Part B drug payment limit file. Multiply by the units billed for the allowed amount before deductible and coinsurance. It is not a coverage decision.
- What is one billing unit of J2260?
- One unit of J2260 is 5 mg, as stated in the code's descriptor. Units to report = dose given ÷ 5 mg. J-code billing units.